San Jose, CA (Vocus) October 13, 2010
Cell culture industry originated in the 1980s through the exploitation of cell hybridization and recombinant de-oxy ribose nucleic acid (DNA) technology. Major application areas of cell/tissue culture include biotechnology, microbiology, medicine, pharmaceuticals, agriculture, cosmetics and food additives. A key legacy of the recession is the blurring distinction between pharma and biotech companies, with more and more players from the pharma sector making aggressive expansion efforts into large molecule research arena – earlier a prerogative of the biotech sector. A potential growth opportunity for biotech companies emerges from the launch of personalized medicine, which enables companies to forge alliances with pharma majors who lack expertise in this field. Cell culture forms a vital part of biopharmaceutical product development as it is used in the production of large sophisticated protein molecules, the primary building blocks for biopharmaceuticals. Ongoing research in the biopharmaceutical market, a key collaborator of the worldwide cell/tissue culture market, represents the major driver for the cell/tissue culture market. In addition, the extended utilization of stem cells in varied applications continues to deliver robust impact on cell culture media.
The US represents the largest market for cell/tissue culture supplies, as stated by the new market research report on Cell/Tissue Culture Supplies. Advances in the cell culture techniques are largely contributing in taking research to large-scale commercial processes. Further, the new US government’s decision revoking the ban on federal funding in the field of embryonic stem cell research and announcement of a stimulus package for scientific research are also likely to spawn activities in the stem-cell and biotech industries. Reagents constitute the largest segment in the cell and tissue culture supplies space. The US market for cell culture media is projected to reach $589 million by 2014. The market continues to witness the transition towards serum-free and protein-free media. Hi-Veg culture media, the animal components free media, is fast gaining acceptance from worldwide researchers.
Key players identified and profiled in the report include Affymetrix Inc., AMRESCO Inc, Analytical Biological Services, BD Biosciences, Cell Culture Technologies, Irvine Scientific, Life Technologies Corporation, Lonza Biologics Plc, Millipore Corporation, PerBio Science AB, PromoCell GmbH, Sera Laboratories International, Sigma-Aldrich Corporation, USB Corp, and Vitrolife AB.
The report titled “Cell/Tissue Culture Supplies: A Global Strategic Business Report” announced by Global Industry Analysts, Inc. covers major market dynamics, trends, regulations, end-use analysis and competition pertaining to the market. The report enumerates recent developments, mergers, acquisitions and other strategic industry activities. Product segments analyzed in the study include Media, Sera, and Reagents. Analysis for the period 2000 through 2015 is presented for established and emerging markets including United States, Canada, Japan, France, Germany, United Kingdom, Italy, Asia-Pacific, and Latin America.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com
# # #